A new 22,26-seco physalin steroid from Physalis angulata

Area of Science:

• Phytochemistry
• Natural Products Chemistry
• Pharmacology

Background:

• Physalis angulata L. is a plant source of bioactive compounds.
• Physalins are a class of natural products with diverse biological activities.
• Understanding the structure-activity relationship of physalins is crucial for drug discovery.

Purpose of the Study:

• To isolate and characterize new compounds from Physalis angulata L.
• To evaluate the in vitro cytotoxicity of isolated compounds against various cancer cell lines.
• To investigate the structural features responsible for the observed cytotoxicity.

Main Methods:

• Isolation of compounds using dichloromethane extraction.
• Structure elucidation of isolated compounds via spectroscopic analysis (e.g., NMR, MS).
• In vitro cytotoxicity assays against human cancer cell lines (HepG2, HeLa, HuCCA-1, T47-D, A-549) and a normal cell line (MRC-5).

Main Results:

• A new 22,26-seco physalin, physalin XI (1), was identified along with five known compounds.
• Physalin XI (1) exhibited no significant cytotoxicity against tested cancer and normal cell lines.
• Compounds 2 and 4 demonstrated high toxicity towards H69AR and MDA-MB-23 cell lines.
• Conjugated double bonds or epoxy groups were identified as key structural features correlating with high toxicity.

Conclusions:

• Physalis angulata L. yields structurally diverse physalins with varying cytotoxic profiles.
• Specific structural motifs, such as conjugated double bonds and epoxy groups, are critical for potent anticancer activity.
• The findings provide insights into the structure-toxicity relationship of physalins, guiding future development of cytotoxic agents.